Derivation of iPS cell line (ICGi032-A) from a patient affected with fragile X syndrome

Trinucleotide repeat expansion diseases such as fragile X syndrome are of great interest to study since the mechanism of its development is still unknown. IPS cell lines are some of the most convenient models for studying. The ICGi032-A iPS cell line was obtained from the peripheral blood mononuclea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: M.M. Gridina, E.M. Shitik, N.A. Lemskaya, J.M. Minina, I.V. Grishchenko, A.A. Dolskiy, A.R. Shorina, Y.V. Maksimova, D.V. Yudkin
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/9668a25f395a403cb606d1f213fc09eb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9668a25f395a403cb606d1f213fc09eb
record_format dspace
spelling oai:doaj.org-article:9668a25f395a403cb606d1f213fc09eb2021-12-04T04:33:29ZDerivation of iPS cell line (ICGi032-A) from a patient affected with fragile X syndrome1873-506110.1016/j.scr.2021.102615https://doaj.org/article/9668a25f395a403cb606d1f213fc09eb2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1873506121004621https://doaj.org/toc/1873-5061Trinucleotide repeat expansion diseases such as fragile X syndrome are of great interest to study since the mechanism of its development is still unknown. IPS cell lines are some of the most convenient models for studying. The ICGi032-A iPS cell line was obtained from the peripheral blood mononuclear cells of the patient affected with fragile X syndrome. ICGi032-A iPS cell line have a normal karyotype, expression of pluripotency markers and can differentiate in vitro into the cells of three germ layers.M.M. GridinaE.M. ShitikN.A. LemskayaJ.M. MininaI.V. GrishchenkoA.A. DolskiyA.R. ShorinaY.V. MaksimovaD.V. YudkinElsevierarticleBiology (General)QH301-705.5ENStem Cell Research, Vol 57, Iss , Pp 102615- (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
M.M. Gridina
E.M. Shitik
N.A. Lemskaya
J.M. Minina
I.V. Grishchenko
A.A. Dolskiy
A.R. Shorina
Y.V. Maksimova
D.V. Yudkin
Derivation of iPS cell line (ICGi032-A) from a patient affected with fragile X syndrome
description Trinucleotide repeat expansion diseases such as fragile X syndrome are of great interest to study since the mechanism of its development is still unknown. IPS cell lines are some of the most convenient models for studying. The ICGi032-A iPS cell line was obtained from the peripheral blood mononuclear cells of the patient affected with fragile X syndrome. ICGi032-A iPS cell line have a normal karyotype, expression of pluripotency markers and can differentiate in vitro into the cells of three germ layers.
format article
author M.M. Gridina
E.M. Shitik
N.A. Lemskaya
J.M. Minina
I.V. Grishchenko
A.A. Dolskiy
A.R. Shorina
Y.V. Maksimova
D.V. Yudkin
author_facet M.M. Gridina
E.M. Shitik
N.A. Lemskaya
J.M. Minina
I.V. Grishchenko
A.A. Dolskiy
A.R. Shorina
Y.V. Maksimova
D.V. Yudkin
author_sort M.M. Gridina
title Derivation of iPS cell line (ICGi032-A) from a patient affected with fragile X syndrome
title_short Derivation of iPS cell line (ICGi032-A) from a patient affected with fragile X syndrome
title_full Derivation of iPS cell line (ICGi032-A) from a patient affected with fragile X syndrome
title_fullStr Derivation of iPS cell line (ICGi032-A) from a patient affected with fragile X syndrome
title_full_unstemmed Derivation of iPS cell line (ICGi032-A) from a patient affected with fragile X syndrome
title_sort derivation of ips cell line (icgi032-a) from a patient affected with fragile x syndrome
publisher Elsevier
publishDate 2021
url https://doaj.org/article/9668a25f395a403cb606d1f213fc09eb
work_keys_str_mv AT mmgridina derivationofipscelllineicgi032afromapatientaffectedwithfragilexsyndrome
AT emshitik derivationofipscelllineicgi032afromapatientaffectedwithfragilexsyndrome
AT nalemskaya derivationofipscelllineicgi032afromapatientaffectedwithfragilexsyndrome
AT jmminina derivationofipscelllineicgi032afromapatientaffectedwithfragilexsyndrome
AT ivgrishchenko derivationofipscelllineicgi032afromapatientaffectedwithfragilexsyndrome
AT aadolskiy derivationofipscelllineicgi032afromapatientaffectedwithfragilexsyndrome
AT arshorina derivationofipscelllineicgi032afromapatientaffectedwithfragilexsyndrome
AT yvmaksimova derivationofipscelllineicgi032afromapatientaffectedwithfragilexsyndrome
AT dvyudkin derivationofipscelllineicgi032afromapatientaffectedwithfragilexsyndrome
_version_ 1718372982885187584